Bayer and Aignostics to collaborate on next generation precision oncology
March 14, 2024 03:30 ET
|
Aignostics GmbH
Not intended for UK Media Strategic multi-year research collaboration to identify novel targets with strong disease links and to accelerate clinical development, further strengthening Bayer’s...
Aignostics Raises €14m Series A to Advance AI-powered Pathology
September 15, 2022 03:00 ET
|
Aignostics GmbH
Oversubscribed financing round with top-tier life science investors, led by Wellington PartnersSpin-off from Charité – Universitätsmedizin Berlin developing sophisticated AI models to improve...